Older adults in cancer clinical trials don’t have more ER, observational visits, data shows
By
Kristen Fischer
Jun 05, 2024
Older people in clinical trials for cancer didn’t have significantly more emergency room or observational visits compared to those not in trials, but they underwent more hospitalizations, according to...
Parkinson’s Foundation expands free, at-home genetic testing initiative
By
Alicia Lasek (f3)
May 06, 2022
The organization is making an effort to connect a broader and more diverse set of candidates to clinical trials.
Opinion: Even with new law, clinical trials lack data on older adults
By
Kristen Fischer
Apr 17, 2024
Older adults are not represented adequately in clinical trials of medications for disorders that are common in the population. The legal framework to better represent them is in place, but not enough is...
Report endorses adding more nursing home residents in clinical trials, shares framework to do so
By
Kristen Fischer
Mar 18, 2024
A commentary published in the Journal of the American Geriatrics Society on March 14 talks about the need for clinical trials among people living in nursing homes.
Report: Caregivers are left out of Alzheimer’s, dementia clinical trials
By
Kristen Fischer
Aug 22, 2023
A new study explores the lack of integration of family caregivers to support their loved ones with Alzheimer’s disease and related dementias (ADRD) who are part of clinical trials.
An Alzheimer’s reality check
By
Tim Mullaney
Nov 12, 2013
Alzheimer’s researchers — or the public relations machines breathlessly trumpeting their work — should chill out. I see so much of this type of Alzheimer’s news that it’s hard to...
CDC briefing: Top officials talk up vaccine plans, focus on long-term care
By
Alicia Lasek
Oct 22, 2020
Federal health officials touted transparency and nationwide distribution plans while keeping their eye on Phase 1 vaccine recipients, including LTC residents and workers.
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
AMDA’s new COVID vaccine PowerPoint can help answer resident, staff concerns
By
Alicia Lasek
Dec 09, 2020
A toolkit created by industry clinicians aims to help long-term care operators address questions about getting vaccinated. A PowerPoint presentation is available to share with staff and residents.
COVID trial vaccines may be inadequate, some FDA advisors fear
By
Alicia Lasek
Oct 26, 2020
The current vaccine trials may be too focused on mild rather than severe disease, some advisors contend. But their arguments got pushback in a meeting streamed on the agency’s YouTube channel.